Star Combo Pharma Limited (ASX:S66)

Market Cap	30.39M +50.0%
Revenue (ttm)	23.99M -18.8%
Net Income	4.12M +499.8%
EPS	0.03 +369.9%
Shares Out	135.08M
PE Ratio	7.37
Forward PE	n/a
Dividend	0.00 (1.64%)
Ex-Dividend Date	Oct 14, 2025

Volume	2,000
Average Volume	14,750
Open	0.2200
Previous Close	0.2250
Day's Range	0.2200 - 0.2250
52-Week Range	0.1300 - 0.2750
Beta	0.27
RSI	58.26
Earnings Date	May 26, 2026

About Star Combo Pharma

Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its products under the Costar, Living Healthy, Amax, and J&K brands. Star Combo Pharma Limited was founded in 2004 and is based in Smithfield, Australia.

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2004
• Employees: 30
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: S66

Financial Performance

In fiscal year 2025, Star Combo Pharma's revenue was 27.81 million, an increase of 6.89% compared to the previous year's 26.02 million. Earnings were 3.98 million, an increase of 432.73%.